Managers / Q2 2024 · view latest →
Brown University
CIK 0001664741 · ONE CITIZENS PLAZA, 4TH FLOOR SUITE 410, PROVIDENCE, RI, 02903 · 4018673998
Summary
Brown University reported $265M in U.S.-listed holdings across 10 positions for Q2 2024.
The portfolio is heavily concentrated: OWL alone accounts for 43.3% of reported value.
The book was largely unchanged from Q1 2024.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 64.7% · $171M
- ETP · 27.7% · $73M
- Other · 5.1% · $14M
- ADR · 2.5% · $7M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SPDR SER TR | ADDED | +238.0K | 268.0K | +$22M | $25M |
| ISHARES INC | ADDED | +144.3K | 386.6K | +$9M | $26M |
| OWLBLUE OWL CAPITAL INC | TRIMMED | −500.0K | 6.46M | −$17M | $115M |
| AMERICAN CENTY ETF TR | HELD | +0 | 245.9K | −$981,141 | $22M |
| PROKIDNEY CORP | HELD | +0 | 1.00M | +$820,000 | $2M |
| ATAI LIFE SCIENCES NV | HELD | +0 | 718.5K | −$459,840 | $955,605 |
| BLUE OWL CAP CORP III | HELD | +0 | 675.1K | −$236,270 | $10M |
| BEKEKE HLDGS INC | HELD | +0 | 438.5K | +$184,189 | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | OWLBLUE OWL CAPITAL INChistory → | COM CL A | 43.31% | $115M | 6.46M |
| 2 | OBDCBLUE OWL CAPITAL CORPORATIONhistory → | COM | 21.40% | $57M | 3.69M |
| 3 | ISHARES INC | MSCI JPN ETF NEW | 9.96% | $26M | 386.6K |
| 4 | SPDR SER TR | S&P BIOTECH | 9.38% | $25M | 268.0K |
| 5 | AMERICAN CENTY ETF TR | US SML CP VALU | 8.33% | $22M | 245.9K |
| 6 | BLUE OWL CAP CORP III | COM SHS | 3.82% | $10M | 675.1K |
| 7 | BEKEKE HLDGS INChistory → | SPONSORED ADS | 2.34% | $6M | 438.5K |
| 8 | PROKIDNEY CORP | CLASS A ORD SHS | 0.93% | $2M | 1.00M |
| 9 | ATAI LIFE SCIENCES NV | SHS | 0.36% | $955,605 | 718.5K |
| 10 | CMPSCOMPASS PATHWAYS PLC | SPONSORED ADS | 0.17% | $439,108 | 72.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $102M | 11 | May 1, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $143M | 10 | Jan 30, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $169M | 8 | Nov 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $142M | 9 | Aug 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $216M | 14 | May 2, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $235M | 12 | Feb 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $247M | 10 | Nov 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $265M | 10 | Jul 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $251M | 10 | May 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $277M | 8 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $250M | 7 | Oct 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $269M | 6 | Aug 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 7 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 5 | Jan 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $247M | 6 | Nov 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $336M | 13 | Jul 29, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $409M | 13 | May 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $410M | 8 | Jan 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $738M | 8 | Oct 25, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $604M | 6 | Jul 30, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $146M | 5 | May 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $138M | 7 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $141M | 6 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $136M | 6 | Jul 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $115M | 5 | Apr 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $184M | 11 | Jan 22, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.